EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

What is really known about the effects of nicotinamide riboside supplementation in humans

Mads V Damgaard iD, Jonas T Treebak iD

Science Advances · 2023

DOI: 10.1126/sciadv.adi4862 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Science Advances, 2023. Verfasst von Mads V Damgaard und 1 weiteren Autor:innen. Beteiligte Einrichtung: Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen 2200, Denma…. Hauptthemen laut MEDLINE: Niacinamide, NAD. Die Arbeit wurde bisher 108-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nicotinamide riboside is a precursor to the important cofactor nicotinamide adenine dinucleotide and has elicited metabolic benefits in multiple preclinical studies. In 2016, the first clinical trial of nicotinamide riboside was conducted to test the safety and efficacy of human supplementation. Many trials have since been conducted aiming to delineate benefits to metabolic health and severe diseases in humans. This review endeavors to summarize and critically assess the 25 currently published research articles on human nicotinamide riboside supplementation to identify any poorly founded claims and assist the field in elucidating the actual future potential for nicotinamide riboside. Collectively, oral nicotinamide riboside supplementation has displayed few clinically relevant effects, and there is an unfortunate tendency in the literature to exaggerate the importance and robustness of reported effects. Even so, nicotinamide riboside may play a role in the reduction of inflammatory states and has shown some potential in the treatment of diverse severe diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NiacinamideNADHumansPyridinium CompoundsDietary Supplements

Substanzen

nicotinamide-beta-ribosideNiacinamideNADPyridinium Compounds

Autor:innen und Institutionen

  • Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen 2200, Denmark.

ORCID-Profile: Mads V Damgaard, Jonas T Treebak

Zitieren

APA

Damgaard, M. V., & Treebak, J. T. (2023). What is really known about the effects of nicotinamide riboside supplementation in humans. Science Advances. https://doi.org/10.1126/sciadv.adi4862

Vancouver

Damgaard MV, Treebak JT. What is really known about the effects of nicotinamide riboside supplementation in humans. Science Advances. 2023. doi:10.1126/sciadv.adi4862

BibTeX
@article{Damgaard2023,
  author = {Damgaard, Mads V and Treebak, Jonas T},
  title = {What is really known about the effects of nicotinamide riboside supplementation in humans},
  journal = {Science Advances},
  year = {2023},
  doi = {10.1126/sciadv.adi4862}
}
Kostenlos starten →